2-Deoxy-D-glucose has distinct and cell line-specific effects on the survival of different cancer cells upon antitumor drug treatment
- PMID: 30375744
- DOI: 10.1111/febs.14687
2-Deoxy-D-glucose has distinct and cell line-specific effects on the survival of different cancer cells upon antitumor drug treatment
Abstract
The dependence of tumors on glycolysis for ATP generation offers a rationale for therapeutic strategies aimed at selective inhibition of the glycolytic pathway. Analysis of tumor cell responses to anticancer drugs revealed that inhibition of glycolysis by 2-deoxy-D-glucose (2-DG) generally augmented the apoptotic response; however, in HCT116 human colon carcinoma cells, apoptosis was suppressed. A comparison of neuroblastoma SK-N-BE(2) and HCT116 cells revealed, that in contrast to HCT116, in SK-N-BE(2) cells 2-DG alone was able to induce cell death. In SK-N-BE(2) cells the decrease in ATP levels upon treatment with 2-DG was more prominent because in HCT116 cells mitochondria compensated for the loss of ATP caused by glycolysis suppression. In both cells lines 2-DG triggered endoplasmic reticulum (ER) stress, assessed by the accumulation of the marker protein GRP78/BiP. Suppression of ER stress by mannose attenuated the 2-DG-induced apoptotic response in SK-N-BE(2) cells, implying that apoptosis in these cells is a consequence of ER stress induction. In HCT116 cells, ER stress stimulated autophagy, assessed by the accumulation of the lipidated form of LC3. The inhibitor of ER stress mannose attenuated autophagy and reversed 2-DG-mediated suppression of cisplatin-induced apoptosis. When autophagy in HCT116 cells was suppressed by bafilomycin, cisplatin-induced apoptosis was decreased. At the same time, stimulation of autophagy in SK-N-BE(2) cells suppressed cell death. Thus, successful treatment of tumors with conventionally used anticancer drugs should be combined with targeting metabolic pathways involved in the regulation of apoptosis, autophagy, and cellular bioenergetics.
Keywords: ER stress; apoptosis; cancer; glycolysis; mitochondria.
© 2018 Federation of European Biochemical Societies.
Similar articles
-
2-Deoxy-D-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion.Cancer Chemother Pharmacol. 2011 Apr;67(4):899-910. doi: 10.1007/s00280-010-1391-0. Epub 2010 Jul 1. Cancer Chemother Pharmacol. 2011. PMID: 20593179 Free PMC article.
-
2-Deoxy-d-Glucose Sensitizes Human Ovarian Cancer Cells to Cisplatin by Increasing ER Stress and Decreasing ATP Stores in Acidic Vesicles.J Biochem Mol Toxicol. 2015 Dec;29(12):572-8. doi: 10.1002/jbt.21730. Epub 2015 Aug 4. J Biochem Mol Toxicol. 2015. PMID: 26241884
-
Resveratrol augments ER stress and the cytotoxic effects of glycolytic inhibition in neuroblastoma by downregulating Akt in a mechanism independent of SIRT1.Exp Mol Med. 2016 Feb 19;48(2):e210. doi: 10.1038/emm.2015.116. Exp Mol Med. 2016. PMID: 26891914 Free PMC article.
-
Cellular toxicity of the metabolic inhibitor 2-deoxyglucose and associated resistance mechanisms.Biochem Pharmacol. 2020 Dec;182:114213. doi: 10.1016/j.bcp.2020.114213. Epub 2020 Sep 3. Biochem Pharmacol. 2020. PMID: 32890467 Review.
-
2-Deoxy-d-Glucose and Its Analogs: From Diagnostic to Therapeutic Agents.Int J Mol Sci. 2019 Dec 29;21(1):234. doi: 10.3390/ijms21010234. Int J Mol Sci. 2019. PMID: 31905745 Free PMC article. Review.
Cited by
-
Insulin-Like Growth Factor 1 (IGF-1) Signaling in Glucose Metabolism in Colorectal Cancer.Int J Mol Sci. 2021 Jun 16;22(12):6434. doi: 10.3390/ijms22126434. Int J Mol Sci. 2021. PMID: 34208601 Free PMC article. Review.
-
The Anticancer Ruthenium Compound BOLD-100 Targets Glycolysis and Generates a Metabolic Vulnerability towards Glucose Deprivation.Pharmaceutics. 2022 Jan 20;14(2):238. doi: 10.3390/pharmaceutics14020238. Pharmaceutics. 2022. PMID: 35213972 Free PMC article.
-
The effects of hypoxia on mitochondrial function and metabolism in gastric cancer cells.Transl Cancer Res. 2021 Feb;10(2):817-826. doi: 10.21037/tcr-20-2598. Transl Cancer Res. 2021. PMID: 35116412 Free PMC article.
-
DNA Aptamer Beacon Probe (ABP) for Monitoring of Adenosine Triphosphate Level in SW480 Cancer Cells Treated with Glycolysis Inhibitor 2-Deoxyglucose.Int J Mol Sci. 2023 May 26;24(11):9295. doi: 10.3390/ijms24119295. Int J Mol Sci. 2023. PMID: 37298245 Free PMC article.
-
Glucose Metabolism Reprogramming in Bladder Cancer: Hexokinase 2 (HK2) as Prognostic Biomarker and Target for Bladder Cancer Therapy.Cancers (Basel). 2023 Feb 3;15(3):982. doi: 10.3390/cancers15030982. Cancers (Basel). 2023. PMID: 36765947 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous